The probiotic for men market is experiencing robust growth, with a projected value of US$ 2,379.0 million in 2024 expected to surge to US$ 4,914.6 million by 2034, boasting a CAGR of 7.50%. This expansion is driven by changing lifestyles, increased awareness of preventative healthcare, and the growing recognition of probiotics’ role in supporting men’s immune function and overall health.
Rising incidence of gut-related problems among men, coupled with a shift towards proactive health management, is fueling demand for tailored solutions to improve men’s gut health. Scientific research highlighting the benefits of probiotics for men’s health is driving consumer interest and adoption.
Growing Factors:
- Increased investments in probiotic strains tailored for men’s health are expanding product availability and visibility.
- Supportive regulatory environment and endorsements from healthcare professionals are boosting consumer confidence.
- Companies are focusing on innovation and education to address misconceptions and myths about probiotics for men’s health.
Key Takeaway for Investors: Investors in the B2B industry growth sector stand to benefit from the burgeoning probiotic for men market. With a projected CAGR of 7.50% and a forecasted value of US$ 4,914.6 million by 2034, strategic investments in research, innovation, and market expansion can yield significant returns.
Business Growth Headlines:
- Probiotic for Men Market Set to Double by 2034, Offering Lucrative Investment Opportunities
- Unlocking the Potential: Probiotic for Men Sector Poised for 7.50% CAGR Growth Through 2034
- Capitalizing on Health Trends: Probiotic for Men Market Primed for Remarkable Expansion
Browse full Report: https://www.futuremarketinsights.com/reports/probiotic-for-men-market
Growing Importance of Lactobacillus-based Probiotics:
- Lactobacillus strains are gaining popularity in the probiotic for men market, with a projected market share of 56.00% in 2024.
- Scientific evidence supporting the positive effects of lactobacillus strains on digestive health and immune function is driving consumer preference.
Dominance of E-commerce Sales Channel:
- E-commerce platforms are dominating the sales channel for probiotics for men, capturing a market share of 39.00% in 2024.
- Convenience and accessibility offered by online platforms align well with consumer preferences for discreet purchasing of sensitive health products.
Key Regional Insights:
- United States: Expected to register a remarkable CAGR of 33.20%, driven by diverse product offerings and rising health awareness.
- China: Projected to experience a CAGR of 15.30%, supported by strategic alliances and growing health consciousness.
- Japan: Anticipated to cover a CAGR of 11.70%, fueled by increasing consumer awareness and dietary shifts.
- Australia and New Zealand: Projected to witness a CAGR of 7.10%, driven by holistic approaches to health and proactive consumer behavior.
- Germany: Expected to maintain steady growth with a CAGR of 3.40%, driven by cultural acceptance and evolving wellness trends.
Key Companies and Collaborations:
- Major players like Probi, Chr. Hansen Holding A/S, and BioGaia are focusing on developing probiotic strains tailored for men’s health.
- Collaborations between Evogene Ltd. and Verb Biotics LLC, APC Microbiome Ireland and Fonterra, and Probi AB and DKSH Business Unit Healthcare are driving innovation and market expansion.
Recent Advancements
- In February 2024, Evogene Ltd. and Verb Biotics LLC partnered to produce new strains of probiotic bacteria. Evogene’s MicroBoost AI tech-engine was used along with Verb Biotics’ microbiome research capabilities for this purpose.
- In October 2023, APC Microbiome Ireland and Fonterra collaborated to produce fresh probiotic products.
- In December 2022, Probi AB and DKSH Business Unit Healthcare partnered to launch two new probiotic supplements for bone health and iron absorption in Singapore.
Key Companies in the Market
- Nestlé
- Bayer
- Unilever
- P&G
- Now Health Group
- Amerifit Brands
- Reckitt
- The Clorox Company
- Solimo
- Physician’s Choice
- Jiangzhong Pharma
- WonderLab
- Kyung Nam Pharm
- CKD LACTO-FIT
- Morishita Jintan
- SUNTORY
Market Segmentation
By Product:
- Liquid Drops
- Powder
- Ready-to-Feed Liquids
- Chewable Tablets
- Gummies
By Sales Channel:
- Hypermarket/Supermarket
- Specialty Stores
- E-Commerce
- Drug Stores & Pharmacies
- Health & Wellness Stores
- Convenience Store
- Departmental Stores
- Mass Grocery Retailers
By Strain Type:
- Lactobacillus
- Streptococcus
- Bifidobacterium
- Propionibacteria
- Enterobacteria
- Saccharomyces
By Region:
- North America
- Latin America
- Asia Pacific
- Middle East and Africa (MEA)
- Europe
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube